Valiant Laboratories (BOM:543998) Cash-to-Debt : N/A (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Valiant Laboratories Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Valiant Laboratories's cash to debt ratio for the quarter that ended in Dec. 2024 was N/A.

The historical rank and industry rank for Valiant Laboratories's Cash-to-Debt or its related term are showing as below:

BOM:543998' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.32 Med: 0.81 Max: 31.35
Current: 1.03

During the past 4 years, Valiant Laboratories's highest Cash to Debt Ratio was 31.35. The lowest was 0.32. And the median was 0.81.

BOM:543998's Cash-to-Debt is ranked better than
50.5% of 1004 companies
in the Drug Manufacturers industry
Industry Median: 1.02 vs BOM:543998: 1.03

Valiant Laboratories Cash-to-Debt Historical Data

The historical data trend for Valiant Laboratories's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Valiant Laboratories Cash-to-Debt Chart

Valiant Laboratories Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Cash-to-Debt

31.35

0.34

0.59

1.88

Valiant Laboratories Quarterly Data
	Mar21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash-to-Debt	Get a 7-Day Free Trial							N/A	1.88	N/A	1.03	N/A

Competitive Comparison of Valiant Laboratories's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Valiant Laboratories's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valiant Laboratories's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valiant Laboratories's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Valiant Laboratories's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Valiant Laboratories Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Valiant Laboratories's Cash to Debt Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1438.233	/	(16.185	+	750.899)
	=	1.87

Valiant Laboratories's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Valiant Laboratories (BOM:543998) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Valiant Laboratories Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Valiant Laboratories's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Valiant Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valiant Laboratories Ltd (BOM:543998) » Definitions » Cash-to-Debt

Traded in Other Exchanges

VALIANTLAB:India

Address

Mulund Goregaon Link Road, 104, Udyog Kshetra, Mulund, MH, IND, 400080

Website

https://www.valiantlabs.in

Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.

Valiant Laboratories Headlines

No Headlines